Endocrine Therapy for Endometrial Carcinoma: Current Evidence, Resistance Mechanisms, and Biomarker-Driven Patient Selection

The treatment landscape for endometrial carcinoma (EC) is undergoing a paradigm shift from traditional histopathological dualism to precision medicine grounded in the Cancer Genome Atlas (TCGA) molecular classification. The “No Specific Molecular Profile” (NSMP) subgroup, the largest molecular cohor...

Полное описание

Библиографические подробности

Главные авторы:	Taro Yamanaka, Hiroshi Yoshida, Tatsunori Shimoi, Kazuki Sudo, Kan Yonemori
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2026-02-01
Серии:	Current Oncology
Предметы:	endometrial cancer estrogen receptor progesterone receptor endocrine therapy progestin selective estrogen receptor degraders
Online-ссылка:	https://www.mdpi.com/1718-7729/33/2/124
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!